BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25145425)

  • 1. Rethinking cancer clinical trials for the future.
    Galsky MD
    Future Oncol; 2014; 10(9):1545-7. PubMed ID: 25145425
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 3. Aiming for the future: clinical trials study the personalized treatments of tomorrow.
    Coghill AS
    ONS Connect; 2013 Dec; 28(4):36-40. PubMed ID: 24400579
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
    McBride D
    ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Much has changed in cancer clinical trials in the past 10 years.
    Wujcik DM
    ONS Connect; 2012 Jul; 27(7):7. PubMed ID: 22855982
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical setbacks for toll-like receptor 9 agonists in cancer.
    Schmidt C
    Nat Biotechnol; 2007 Aug; 25(8):825-6. PubMed ID: 17687345
    [No Abstract]   [Full Text] [Related]  

  • 8. How can we improve clinical trials?
    Kaplan RS
    Nat Clin Pract Oncol; 2007 Apr; 4(4):206-7. PubMed ID: 17392712
    [No Abstract]   [Full Text] [Related]  

  • 9. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A; Schilsky RL; Nevins JR
    Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of parenteral antineoplastic agents.
    Cusack G
    J Intraven Nurs; 1998; 21(6):339-43. PubMed ID: 10392099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand.
    Dodgshun AJ; De Silva MP; Bradbeer P; Cross S
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):630-4. PubMed ID: 24577541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trials and tribulations.
    Nat Rev Drug Discov; 2007 May; 6(5):331. PubMed ID: 17539051
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncology drug discovery: planning a turnaround.
    Toniatti C; Jones P; Graham H; Pagliara B; Draetta G
    Cancer Discov; 2014 Apr; 4(4):397-404. PubMed ID: 24706659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical cancer research 2001: new agents and therapies.
    Verweij J; de Vries EG
    Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676
    [No Abstract]   [Full Text] [Related]  

  • 15. Accrual to Cancer Clinical Trial.
    Kelly C; Smith M; Flynn S; Reyes A; Higgins M; McCaffrey J; Kelly C
    Ir Med J; 2016 Aug; 109(7):436. PubMed ID: 27834087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer treatment and the older patient.
    Trimble EL; Christian MC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1956-7. PubMed ID: 16609002
    [No Abstract]   [Full Text] [Related]  

  • 17. Enrichment designs: efficiency in development of cancer treatments.
    Temple RJ
    J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. Current clinical trials of bortezomib.
    Wright JJ; Zerivitz K; Schoenfeldt M
    Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
    [No Abstract]   [Full Text] [Related]  

  • 19. From darkness to light with biomarkers in early clinical trials of cancer drugs.
    Carden CP; Banerji U; Kaye SB; Workman P; de Bono JS
    Clin Pharmacol Ther; 2009 Feb; 85(2):131-3. PubMed ID: 19151637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemoprevention of cancer: directions for the future.
    Daly MB
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):509-12. PubMed ID: 8268765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.